GFC Life Science Co., Ltd (KOSDAQ:388610)
4,270.00
+130.00 (3.14%)
At close: Nov 10, 2026
| Market Cap | 22.48B -71.0% |
| Revenue (ttm) | 19.24B +12.3% |
| Net Income | 1.08B -69.5% |
| EPS | 204.54 -77.7% |
| Shares Out | 5.26M |
| PE Ratio | 20.88 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,246 |
| Open | 4,545.00 |
| Previous Close | 4,140.00 |
| Day's Range | 4,060.00 - 4,545.00 |
| 52-Week Range | 3,805.00 - 16,390.00 |
| Beta | 0.84 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 16, 2026 |